Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Long, Georgina V, MD, Stroyakovskiy, Daniil, MD, Gogas, Helen, MD, Levchenko, Evgeny, MD, de Braud, Filippo, MD, Larkin, James, FRCP, Garbe, Claus, Prof, Jouary, Thomas, MD, Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Chiarion-Sileni, Vanna, MD, Lebbe, Celeste, Prof, Mandalà, Mario, MD, Millward, Michael, Prof, Arance, Ana, MD, Bondarenko, Igor, Prof, Haanen, John B A G, Prof, Hansson, Johan, Prof, Utikal, Jochen, Prof, Ferraresi, Virginia, MD, Kovalenko, Nadezhda, Prof, Mohr, Peter, MD, Probachai, Volodymr, MD, Schadendorf, Dirk, Prof, Nathan, Paul, MD, Robert, Caroline, MD, Ribas, Antoni, Prof, DeMarini, Douglas J, PhD, Irani, Jhangir G, MA, Swann, Suzanne, PhD, Legos, Jeffrey J, PhD, Jin, Fan, MD, Mookerjee, Bijoyesh, MD, Flaherty, Keith, MD
Published in The Lancet (British edition) (01.08.2015)
Published in The Lancet (British edition) (01.08.2015)
Get full text
Journal Article
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Wolchok, Jedd D, Dr, Neyns, Bart, MD, Linette, Gerald, MD, Negrier, Sylvie, Prof, Lutzky, Jose, MD, Thomas, Luc, Prof, Waterfield, William, MD, Schadendorf, Dirk, Prof, Smylie, Michael, Prof, Guthrie, Troy, MD, Grob, Jean-Jacques, Prof, Chesney, Jason, MD, Chin, Kevin, MD, Chen, Kun, PhD, Hoos, Axel, MD, O'Day, Steven J, MD, Lebbé, Celeste, Prof
Published in The lancet oncology (01.02.2010)
Published in The lancet oncology (01.02.2010)
Get full text
Journal Article
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial
Coens, Corneel, MSc, Suciu, Stefan, PhD, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Celeste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Bottomley, Andrew, PhD, Kotapati, Srividya, PharmD, de Pril, Veerle, Testori, Alessandro, MD, Eggermont, Alexander M M, Prof
Published in The lancet oncology (01.03.2017)
Published in The lancet oncology (01.03.2017)
Get full text
Journal Article
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Kaufman, Howard L, Prof, Russell, Jeffery, MD, Hamid, Omid, MD, Bhatia, Shailender, MD, Terheyden, Patrick, MD, D'Angelo, Sandra P, MD, Shih, Kent C, MD, Lebbé, Céleste, Prof, Linette, Gerald P, MD, Milella, Michele, MD, Brownell, Isaac, MD, Lewis, Karl D, MD, Lorch, Jochen H, MD, Chin, Kevin, MD, Mahnke, Lisa, MD, von Heydebreck, Anja, PhD, Cuillerot, Jean-Marie, MD, Nghiem, Paul, Prof
Published in The lancet oncology (01.10.2016)
Published in The lancet oncology (01.10.2016)
Get full text
Journal Article
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Eggermont, Alexander M M, Prof, Chiarion-Sileni, Vanna, MD, Grob, Jean-Jacques, Prof, Dummer, Reinhard, Prof, Wolchok, Jedd D, MD, Schmidt, Henrik, MD, Hamid, Omid, MD, Robert, Caroline, Prof, Ascierto, Paolo A, Prof, Richards, Jon M, MD, Lebbé, Céleste, Prof, Ferraresi, Virginia, MD, Smylie, Michael, MD, Weber, Jeffrey S, MD, Maio, Michele, MD, Konto, Cyril, MD, Hoos, Axel, MD, de Pril, Veerle, MSc, Gurunath, Ravichandra Karra, MD, de Schaetzen, Gaetan, PhD, Suciu, Stefan, PhD, Testori, Alessandro, MD
Published in The lancet oncology (01.05.2015)
Published in The lancet oncology (01.05.2015)
Get full text
Journal Article
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Ascierto, Paolo A, Dr, Del Vecchio, Michele, MD, Robert, Caroline, Prof, Mackiewicz, Andrzej, Prof, Chiarion-Sileni, Vanna, MD, Arance, Ana, MD, Lebbé, Céleste, Prof, Bastholt, Lars, MD, Hamid, Omid, MD, Rutkowski, Piotr, Prof, McNeil, Catriona, MD, Garbe, Claus, Prof, Loquai, Carmen, MD, Dreno, Brigitte, Prof, Thomas, Luc, Prof, Grob, Jean-Jacques, Prof, Liszkay, Gabriella, Prof, Nyakas, Marta, MD, Gutzmer, Ralf, Prof, Pikiel, Joanna, MD, Grange, Florent, MD, Hoeller, Christoph, MD, Ferraresi, Virginia, MD, Smylie, Michael, MD, Schadendorf, Dirk, Prof, Mortier, Laurent, Prof, Svane, Inge Marie, MD, Hennicken, Delphine, MSc, Qureshi, Anila, MD, Maio, Michele, MD
Published in The lancet oncology (01.05.2017)
Published in The lancet oncology (01.05.2017)
Get full text
Journal Article
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
McArthur, Grant A, Prof, Chapman, Paul B, Prof, Robert, Caroline, MD, Larkin, James, MD, Haanen, John B, MD, Dummer, Reinhard, Prof, Ribas, Antoni, Prof, Hogg, David, Prof, Hamid, Omid, MD, Ascierto, Paolo A, MD, Garbe, Claus, Prof, Testori, Alessandro, MD, Maio, Michele, MD, Lorigan, Paul, MD, Lebbé, Celeste, Prof, Jouary, Thomas, MD, Schadendorf, Dirk, Prof, O'Day, Stephen J, MD, Kirkwood, John M., Prof, Eggermont, Alexander M, Prof, Dréno, Brigitte, Prof, Sosman, Jeffrey A, Prof, Flaherty, Keith T, MD, Yin, Ming, PhD, Caro, Ivor, MD, Cheng, Suzanne, PhD, Trunzer, Kerstin, PhD, Hauschild, Axel, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Dabrafenib plus trametinib in patients with BRAFV600 -mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Davies, Michael A, Dr, Saiag, Philippe, Prof, Robert, Caroline, Prof, Grob, Jean-Jacques, Prof, Flaherty, Keith T, Prof, Arance, Ana, MD, Chiarion-Sileni, Vanna, MD, Thomas, Luc, Prof, Lesimple, Thierry, MD, Mortier, Laurent, Prof, Moschos, Stergios J, MD, Hogg, David, MD, Márquez-Rodas, Iván, Prof, Del Vecchio, Michele, Prof, Lebbé, Céleste, Prof, Meyer, Nicolas, Prof, Zhang, Ying, PhD, Huang, Yingjie, MD, Mookerjee, Bijoyesh, MD, Long, Georgina V, Prof
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article